Ms. Evi Mattil, CCO, will to take over the CEO functions ad interim

May 31, 2013 Group News
Tags
, ,

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces today that following on Mr. Arnoud van Tulder’s retirement as Chief Executive Officer, effective June 1, 2013, Ms. Evi Mattil, Chief Commercial Officer, will to take over with immediate effect and on an ad interim basis the functions of Arnoud van Tulder. The search and formal procedure for the nomination of a new CEO will be started immediately.

Resignation Mr. Arnoud van Tulder as CEO

May 30, 2013 Group News
Tags

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces today that Mr. Arnoud van Tulder will for personal reasons retire as Chief Executive Officer, effective June 1, 2013.

read more

EN – New CEO appointment

February 4, 2010 Group News

Arnoud van Tulder appointed Chief Executive

Cryo-Save Group N.V. (AIM/Euronext: CRYO, “Cryo-Save” or “the Group”), Europe’s leading stem cell bank, has appointed Arnoud van Tulder (48) as Chief Executive Officer with effect from 1 May 2010. Arnoud, currently Chief Financial Officer of Cryo-Save, will succeed Marc Waeterschoot (60), who will remain on the Board as an Executive Director.

read more

NL – New CEO appointment

February 4, 2010 Group News

Arnoud van Tulder nieuwe CEO Cryo-Save Group

Cryo-Save Group N.V. (AIM/Euronext: CRYO, “Cryo-Save” of “de Groep”), de grootste stamcelbank van Europa, kondigt aan dat Arnoud van Tulder (48), momenteel Chief Financial Officer van de Groep, met ingang van 1 mei 2010 zal worden benoemd tot Chief Executive Officer. Arnoud van Tulder zal Marc Waeterschoot (60) opvolgen, die evenwel aanblijft als Executive Director in de Board of Directors.

read more